Case Report
Published on 06 Sep 2022
Case report: Open bite as an extrapyramidal side effect with aripiprazole, a dopamine partial agonist
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.976387
- 2,177 views
- 8 citations
Type at least 3 characters
531 articles
Articles
Original Research
Published on 06 Sep 2022
Respondents of health survey powered by the innovative NURO app exhibit correlations between exercise frequencies and diet habits, and between stress levels and sleep wellness
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.945780
- 2,097 views
Clinical Trial
Published on 31 Aug 2022
Flurbiprofen used in one-lung ventilation improves intraoperative regional cerebral oxygen saturation and reduces the incidence of postoperative delirium
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.889637
- 2,337 views
- 9 citations
Original Research
Published on 24 Aug 2022
Remote self-administration of digital cognitive tests using the Brief Assessment of Cognition: Feasibility, reliability, and sensitivity to subjective cognitive decline
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.910896
- 3,514 views
- 8 citations
Perspective
Published on 22 Aug 2022
What is better for psychiatry: Titrated or fixed concentrations of nitrous oxide?
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.773190
- 1,935 views
- 4 citations
Original Research
Published on 12 Aug 2022
URB597 induces subtle changes to aggression in adult Lister Hooded rats
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.885146
- 1,651 views
- 3 citations
Original Research
Published on 11 Aug 2022
Efficacy of a novel proprietary dietary supplement (TRI 360TM) on psychological symptoms and stress-related quality of life in adult subjects: A randomized controlled clinical trial
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.919284
- 3,009 views
- 3 citations
Original Research
Published on 09 Aug 2022
Associations of digital neuro-signatures with molecular and neuroimaging measures of brain resilience: The altoida large cohort study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.899080
- 3,474 views
- 6 citations
Original Research
Published on 03 Aug 2022
Synthetic cannabinoids use in a sample of opioid-use disorder patients
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.956120
- 2,887 views
- 3 citations
Case Report
Published on 01 Aug 2022
Case Report: Functional and Symptomatic Improvement With Cariprazine in Various Psychiatric Patients: A Case Series
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.878889
- 3,625 views
- 4 citations
Mini Review
Published on 28 Jul 2022
Ketamine as a prophylactic resilience-enhancing agent
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.833259
- 7,027 views
- 16 citations
Editorial
Published on 26 Jul 2022
Editorial: Natural products as sources of innovative approaches in psychiatry
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.929139
- 1,152 views
Original Research
Published on 25 Jul 2022
5:2 intermittent fasting tapers food intake in the refeeding state and ameliorates metabolic disturbances in mice exposed to olanzapine
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.926251
- 2,942 views
- 2 citations
Case Report
Published on 25 Jul 2022
Case report: Intranasal esketamine for severe major depressive disorder with psychotic features
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.937996
- 4,920 views
- 4 citations
Case Report
Published on 22 Jul 2022
Case report: Effectiveness of brexpiprazole and esketamine/ketamine combination: A novel therapeutic strategy in five cases of treatment-resistant depression
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.890099
- 5,058 views
- 1 citation
Original Research
Published on 22 Jul 2022
Intramuscular ketamine vs. escitalopram and aripiprazole in acute and maintenance treatment of patients with treatment-resistant depression: A randomized double-blind clinical trial
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.830301
- 8,259 views
- 2 citations